Clinical News

⚠️ Safety Alert

MHRA 29 Jan 2026

GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists: strengthened warnings on acute pancreatitis, including necrotising and fatal cases

The product information for all Glucagon-Like Peptide-1 (GLP-1) receptor agonists and dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonists has been…

⚠️ Safety Alert

MHRA 24 Oct 2024

GLP-1 receptor agonists: reminder of the potential side effects and to be aware of the potential for misuse

Healthcare professionals are reminded to inform patients about the common and serious side effects associated with glucagon-like peptide-1 receptor agonists…

⚠️ Safety Alert

MHRA 24 Oct 2024

Insulin pumps and continuous glucose monitoring (CGM) equipment: guidance for users on reporting suspected adverse incidents and safety concerns to the MHRA’s Yellow Card scheme

We ask healthcare professionals to support new guidance for users of diabetes management equipment, their families, care givers and representatives.

GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists: strengthened warnings on acute pancreatitis, including necrotising and fatal cases

GLP-1 receptor agonists: reminder of the potential side effects and to be aware of the potential for misuse

Insulin pumps and continuous glucose monitoring (CGM) equipment: guidance for users on reporting suspected adverse incidents and safety concerns to the MHRA’s Yellow Card scheme

Join 10,000+ UK Clinicians